Hims & Hers AI Cuts Routine Support Tasks Nearly 50%
Summary
Hims & Hers says its weight-loss care AI reduced nonclinical support tasks nearly 50%, but it has not quantified the cost or margin impact.
On August 10, 2026, Hims & Hers Health (HIMS) said its Hers weight-loss care AI had reduced the nonclinical tasks handled by its support team by nearly 50%. That operating result does not establish that support costs fell or margins improved by the same amount.[1]
Hims & Hers Health, Inc. (HIMS) is a direct-to-consumer telehealth platform that connects patients with independent healthcare providers through online consultations and offers ongoing treatment and related products for needs including weight loss, sexual health, and skin care. Its AI care journey companion now participates in routine communication during weight-loss treatment. It answers common questions about topics such as order status and general side effects, provides draft responses to care teams, and refers matters requiring clinical judgment—such as dosage adjustments or treatment changes—to clinicians. Clinicians remain responsible for clinical decisions, so the system is part of both the company's core care workflow and its everyday support operations.
From an AI care concept to limited production
The AI care journey companion evolved from a vision for continuous support into a human-reviewed assistance tool and then became part of a unified weight-loss care experience. On February 24, 2025, the company described AI coaches, therapists, nutritionists, and trainers that could provide around-the-clock lifestyle and follow-up support. At that point, it had not disclosed a launch or an actual result.[3]
By May 2026, an AI copilot for care staff was live: the system drafted responses that care staff reviewed before sending.[2] By August 10, 2026, the earlier coaching, proactive communication, care-copilot, and clinical-escalation functions had carried forward into a unified, AI-native Hers weight-loss experience. Its phased rollout remained limited to participating customers in that business.[1]
Higher engagement, with important measurement gaps
Hers customers participating in the new care experience sent three times as many messages on the platform as under the company's comparison basis, and AI answered 80% of their questions.[1] The system therefore handled most questions even as engagement increased. However, the company did not disclose the customer sample, absolute message volume, observation period, control-group definition, question categories, or answer quality. The figures do not directly demonstrate better clinical outcomes or retention.
The clearest operating signal—and what remains unknown
The result closest to a business outcome is the nearly 50% reduction in nonclinical tasks handled by the support team, including order updates and general side-effect questions.[1] One possible pathway is that AI handles routine matters first, allowing support staff to spend time on issues requiring human judgment. If support hours required per customer decline as deployment expands, operating expense growth could slow and operating margin could benefit. The relevant financial measures to watch are operating expenses and operating margin.
The company said its operations and support functions delivered three percentage points of sequential leverage and attributed that result partly to AI customer-service initiatives already deployed. Pharmacy efficiency was also a driver, however, and the company did not separately disclose the hours, expenses, or margin contribution saved by this application.
Hims & Hers has moved the care journey companion from a concept into limited production and confirmed that it changed routine questions and support workloads for participating customers. Whether it produces identifiable operating leverage will depend on support hours or support costs per customer after a broader rollout, as well as expense savings that can be attributed specifically to the application.
Application assessment
- AI Care Journey Companion | Business position: Core operations | Deployment stage: Limited production | Scope: Single business unit | Value type: Cost reduction
Sources
[1] Drillr · Hims & Hers Health, Inc. (HIMS) · 2026-08-10 · Earnings call
Original: Hers customers using the new care experience are sending three times as many messages on the platform, with AI answering 80% of their questions to support their treatment journey.
[2] Drillr · Hims & Hers Health, Inc. (HIMS) · 2026-05-11 · Earnings call
Original: For example, we currently have an AI co-pilot live on the provider side of the platform that draft contextual responses on behalf of our care coaches, which are then reviewed by the care coaches before being sent.
[3] Drillr · Hims & Hers Health, Inc. (HIMS) · 2025-02-24 · Earnings call
Original: In this next-generation of health care, we see a world where AI can substantially elevate the subscriber experience by providing resources with greater sophistication such as AI coaches, therapists, nutritionists, and trainers available for 24/7 on-demand support to help our customers make meaningful lifestyle changes in pursuit of their health and wellness goals.